The effect of tumor mutation burden on immune checkpoint inhibitors in non-small cell lung cancer.

被引：0
|
作者：
Zhao, Jie [1 ]
Dong, Yiting [1 ]
Bai, Hua [1 ]
Duan, Jianchun [1 ]
Wang, Guoqiang [2 ]
Xu, Jiachen [1 ]
Wang, Zhijie [1 ]
Wang, Jie [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Beijing, Peoples R China
[2] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1614
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients
    He, Xin
    Wei, Shan-Na
    Qin, Wen-Wen
    Geng, Nan
    Li, Bin
    Song, Shan
    Wang, Ping
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (12) : 1135 - 1142
  • [42] Effect and safety of immune checkpoint inhibitors for brain metastases from non-small cell lung cancer
    Iuchi, T.
    Ashinuma, H.
    Yoshida, Y.
    Mizuno, S.
    Hosono, J.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    Shingyoji, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 622 - 622
  • [43] Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden
    Muto, Satoshi
    Ozaki, Yuki
    Yamaguchi, Hikaru
    Mine, Hayato
    Takagi, Hironori
    Watanabe, Masayuki
    Inoue, Takuya
    Yamaura, Takumi
    Fukuhara, Mitsuro
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Osugi, Jun
    Hoshino, Mika
    Higuchi, Mitsunori
    Shio, Yutaka
    Nanamiya, Hideaki
    Imai, Jun-Ichi
    Isogai, Takao
    Watanabe, Shinya
    Suzuki, Hiroyuki
    ONCOLOGY LETTERS, 2021, 21 (03)
  • [44] Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases
    Wei Yuxi
    Xu Yan
    Wang Mengzhao
    中华医学杂志英文版, 2023, 136 (13)
  • [45] Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer
    Itsuki Yuasa
    Masatsugu Hamaji
    Hiroaki Ozasa
    Yuichi Sakamori
    Hironori Yoshida
    Yojiro Yutaka
    Toshi Menju
    Toyohiro Hirai
    Hiroshi Date
    General Thoracic and Cardiovascular Surgery, 2023, 71 : 534 - 541
  • [46] Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Alfranca, Yolanda Lage
    Garcia, Maria Eugenia Olmedo
    Rueda, Ana Gomez
    Ballesteros, Pablo Alvarez
    Rodriguez, Diana Rosero
    Velasco, Marisa Torres
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [47] Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
    Zhou, Kexun
    Li, Shuo
    Zhao, Yi
    Cheng, Ke
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases
    Wei, Yuxi
    Xu, Yan
    Wang, Mengzhao
    CHINESE MEDICAL JOURNAL, 2023, 136 (13) : 1523 - 1531
  • [49] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Shinkichi Takamori
    Mototsugu Shimokawa
    Takefumi Komiya
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13175 - 13184
  • [50] Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
    Lim, Sung Won
    Ahn, Myung-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (01): : 50 - 59
12345